Track topics on Twitter Track topics that are important to you
November 9, 2018, Mperia’s Board of Directors announces today the appointment of Mr Paul Chipperton, as the new President and CEO, effective immediately. He will lead CD36 devel...
CEO & President Paul Chipperton is pleased to announce today the appointment of Dr Daniel Saban, PhD; Dr Szilard Voros PhD, MD; and Dr Jean-Christophe Leroux, PhD; to the comp...
We have published hundreds of Mperia news stories on BioPortfolio along with dozens of Mperia Clinical Trials and PubMed Articles about Mperia for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Mperia Companies in our database. You can also find out about relevant Mperia Drugs and Medications on this site too.